Literature DB >> 3515313

Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections.

E Stolz, M J Tegelberg-Stassen, A H Van der Willigen, J C Van der Hoek, T Van Joost, L Mooi, J H Wagenvoort.   

Abstract

123 Female patients suffering from uncomplicated urogenital gonorrhoea were treated with either 200 mg or 400 mg enoxacin. The cure rate in the 400 mg group was 100%; the cure rate in the 200 mg group was 95.7% 212 Male patients suffering from urethral gonorrhoea were treated with either 250 mg or 500 mg ciprofloxacin (one tablet). Cure rates in both groups were 100%. Post-gonococcal urethritis was observed in 31 out of 85 (36%) patients in the first, and 21 out of 79 (27%) in the second group. In a pilot study 42 male patients suffering from non-gonococcal urethritis were treated during one week with I g ciprofloxacin daily. In 22 patients Chlamydia trachomatis was isolated from the urethra: in 20 of these 22 cases Chlamydia trachomatis could not be cultured after treatment (cure rate 91%), but in 4 of these 20 cases (20%) and in 8 of the 20 Chlamydia trachomatis negative cases (40%) urine-sediment abnormalities were present after treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3515313     DOI: 10.1007/bf01975482

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  6 in total

1.  A double blind study comparing two dosages of enoxacin for the treatment of uncomplicated urogenital gonorrhoea.

Authors:  A Notowicz; E Stolz; B van Klingeren
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

2.  Sensitivity to ampicillin, penicillin, and tetracyline of gonococci in Rotterdam.

Authors:  E Stolz; H G Zwart; M F Michel
Journal:  Br J Vener Dis       Date:  1974-06

3.  The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.

Authors:  G L Ridgway; G Mumtaz; F G Gabriel; J D Oriel
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

4.  Single dose ciprofloxacin for treating gonococcal infections in men.

Authors:  P S Loo; G L Ridgway; J D Oriel
Journal:  Genitourin Med       Date:  1985-10

5.  In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

6.  The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity.

Authors:  D S Reeves; M J Bywater; H A Holt
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

  6 in total
  5 in total

1.  In vitro activity and mode of action of fluoroquinolones.

Authors:  L Verbist
Journal:  Pharm Weekbl Sci       Date:  1987-12-11

2.  Clinical efficacy of ciprofloxacin versus doxycycline in the treatment of non-gonococcal urethritis in males.

Authors:  A H van der Willigen; A A Polak-Vogelzang; L Habbema; J H Wagenvoort
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

Review 3.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 4.  Worldwide clinical data on efficacy and safety of ciprofloxacin.

Authors:  P Schacht; G Arcieri; J Branolte; H Bruck; V Chyský; E Griffith; G Gruenwaldt; R Hullmann; C A Konopka; B O'Brien
Journal:  Infection       Date:  1988       Impact factor: 3.553

5.  Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women.

Authors:  Carol Páez-Canro; Juan Pablo Alzate; Lina M González; Jorge Andres Rubio-Romero; Anne Lethaby; Hernando G Gaitán
Journal:  Cochrane Database Syst Rev       Date:  2019-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.